Udit Verma

  • 1905 Citations
  • 20 h-Index
1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Interleukin-2 Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
irinotecan Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Phosphotransferases Chemical Compounds
Cyclin D1 Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 1905 Citations
  • 20 h-Index
  • 45 Article
  • 1 Letter

Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?

Stern, J. H., Arriaga, Y. E., Gupta, A., Verma, U., Karri, S., Syed, S. K., Khosama, L., Mansour, J., Meyer, J., Scherer, P. E. & Beg, M. S., Jan 1 2019, In : Pancreas. 48, 1, p. E1-E3

Research output: Contribution to journalLetter

Tumor Biomarkers
Glucagon
Pancreatic Neoplasms
Fasting
Glucose

Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study

Van Cutsem, E., Martinelli, E., Cascinu, S., Sobrero, A., Banzi, M., Seitz, J. F., Barone, C., Ychou, M., Peeters, M., Brenner, B., Hofheinz, R. D., Maiello, E., André, T., Spallanzani, A., Garcia-Carbonero, R., Arriaga, Y. E., Verma, U., Grothey, A., Kappeler, C., Miriyala, A. & 3 othersKalmus, J., Falcone, A. & Zaniboni, A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Therapeutics
Disease-Free Survival
Safety
regorafenib
7 Citations

A phase II, randomized, double-blind, placebo-controlled study of simtuzumab in combination with FOLFIRI for the Second-Line treatment of metastatic KRAS mutant colorectal adenocarcinoma

Randolph Hecht, J., Benson, A. B., Vyushkov, D., Yang, Y., Bendell, J. & Verma, U., Mar 1 2017, In : Oncologist. 22, 3

Research output: Contribution to journalArticle

Colorectal Neoplasms
Adenocarcinoma
Placebos
irinotecan
Disease-Free Survival
3 Citations

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer

The DIGEST Study Group, 2017, In : Annals of Oncology. 28, 9, p. 2142-2148 7 p.

Research output: Contribution to journalArticle

Fluorouracil
Cisplatin
Stomach Neoplasms
Adenocarcinoma
Safety